Vol. 39 No. 2, March/April 2002

VA Rehabilitation Research & Development Service RR&D Main Page

Cover JRR&D 2002 About the Art

163 Disability and treatment patterns of multiple sclerosis patients in United States: A comparison ofveterans and nonveterans

         Timothy L. Vollmer, MD; Olympia Hadjimichael, MPH; Jana Preiningerova, MD; Weijia Ni, PhD;
Joan Buenconsejo, MS

175 Epidemiology and current treatment of multiple sclerosis in Europe today

         Carlo Pozzilli, MD, PhD; Silvia Romano, MD; Stefania Cannoni, MD

187 The immunopathogenesis of multiple sclerosis

         Elisabetta Prat, MD, and Roland Martin, MD

201 New insights into the genetics of multiple sclerosis

         Sergio E. Baranzini, PhD; Jorge R. Oksenberg, PhD; Stephen L. Hauser, MD

211 Fatigue in multiple sclerosis: Current understanding and future directions

         Steven R. Schwid, MD; Melissa Covington, BS; Benjamin M. Segal, MD;Andrew D. Goodman, MD

225 Pain in multiple sclerosis: A biopsychosocial perspective

         Robert D. Kerns, PhD; Marilyn Kassirer, MD; John Otis, PhD

233 Sodium channels as molecular targets in multiple sclerosis

         Stephen G. Waxman, MD, PhD

234 MR-based technology for in vivo detection, characterization, and quantification of pathology of relapsing-remitting multiple sclerosis

        Marco Rovaris, MD, and Massimo Filippi, MD

261 Magnetic resonance imaging in primary progressive multiple sclerosis

            Gordon T. Ingle, MRCP; Alan J. Thompson, FRCP; David H. Miller, FRCP

273 Immunotherapy of multiple sclerosis-Current practice and future directions

            Mark J. Tullman, MD; Fred D. Lublin, MD; Aaron E. Miller, MD

287 Cell transplantation of peripheral-myelin-forming cells to repair the injured spinal cord

            Jeffery D. Kocsis, PhD; Yukinori Akiyama, MD, PhD; Karen L. Lankford, PhD; and Christine Radtke

299 An overview of assistive technology for persons with multiple sclerosis

            Donna Jo Blake, MD, and Cathy Bodine, PhD, CCC-SLP